I received the following e-mail from Dr. Knoll regarding (-)BPAP dosage and thought it might be of interest
In animal experiments BPAP is about 100 times more potent than deprenyl.
Nevertheless, because of the unusually high safety margine of BPAP, the
starting dose with this compound in human trial was nearly the same which
we used decades ago when we started the first trial with deprenyl. If you are
interested in details read my recent monograph (The Brain and Its Self,
Springer 2005).
Perhaps someone here can access the monograph in question and post the relevant sections
One question would be the dosage of deprenyl to be used